News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
249,059 Results
Type
Article (20642)
Company Profile (105)
Press Release (228312)
Section
Business (78379)
Career Advice (825)
Deals (12422)
Drug Delivery (72)
Drug Development (24903)
Employer Resources (140)
FDA (4791)
Job Trends (6405)
News (121902)
Policy (9925)
Tag
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1529)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (21)
Alliances (22962)
ALS (28)
Alzheimer's disease (599)
Antibody-drug conjugate (ADC) (66)
Approvals (4813)
Artificial intelligence (127)
Autoimmune disease (6)
Automation (7)
Bankruptcy (56)
Best Places to Work (5149)
BIOSECURE Act (11)
Biosimilars (61)
Biotechnology (68)
Bladder cancer (29)
Brain cancer (7)
Breast cancer (95)
Cancer (725)
Cardiovascular disease (62)
Career advice (728)
Career pathing (30)
CAR-T (52)
Cell therapy (151)
Cervical cancer (8)
Clinical research (19566)
Collaboration (410)
Compensation (85)
Complete response letters (9)
COVID-19 (1066)
CRISPR (17)
C-suite (120)
Cystic fibrosis (39)
Data (705)
Decentralized trials (1)
Denatured (21)
Depression (15)
Diabetes (72)
Diagnostics (2712)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (59)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (47)
Earnings (20632)
Editorial (11)
Employer branding (23)
Employer resources (118)
Events (34515)
Executive appointments (377)
FDA (5187)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (354)
Gene editing (39)
Generative AI (14)
Gene therapy (110)
GLP-1 (319)
Government (1465)
Grass and pollen (1)
Guidances (20)
Healthcare (5693)
Huntington's disease (13)
IgA nephropathy (12)
Immunology and inflammation (25)
Indications (7)
Infectious disease (1125)
Inflammatory bowel disease (63)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (39)
Interviews (116)
IPO (4809)
IRA (16)
Job creations (1477)
Job search strategy (639)
Kidney cancer (1)
Labor market (31)
Layoffs (160)
Leadership (9)
Legal (2013)
Liver cancer (36)
Lung cancer (111)
Lymphoma (56)
Machine learning (1)
Management (42)
Manufacturing (133)
MASH (16)
Medical device (3469)
Medtech (3473)
Mergers & acquisitions (7887)
Metabolic disorders (223)
Multiple sclerosis (39)
NASH (10)
Neurodegenerative disease (29)
Neuropsychiatric disorders (4)
Neuroscience (799)
NextGen: Class of 2025 (2206)
Non-profit (1701)
Northern California (842)
Now hiring (36)
Obesity (135)
Opinion (95)
Ovarian cancer (32)
Pain (32)
Pancreatic cancer (19)
Parkinson's disease (51)
Partnered (12)
Patents (59)
Patient recruitment (24)
Peanut (13)
People (29546)
Pharmaceutical (26)
Pharmacy benefit managers (1)
Phase I (5622)
Phase II (8141)
Phase III (7622)
Pipeline (348)
Podcasts (29)
Policy (49)
Postmarket research (756)
Preclinical (2870)
Press Release (62)
Prostate cancer (29)
Psychedelics (18)
Radiopharmaceuticals (74)
Rare diseases (132)
Real estate (2912)
Recruiting (54)
Regulatory (7131)
Reports (38)
Research institute (1310)
Resumes & cover letters (106)
Rett syndrome (1)
RNA editing (1)
RSV (24)
Schizophrenia (27)
Series A (74)
Series B (43)
Service/supplier (8)
Sickle cell disease (22)
Southern California (652)
Special edition (8)
Spinal muscular atrophy (54)
Sponsored (13)
Startups (2190)
State (1)
Stomach cancer (7)
Supply chain (23)
The Weekly (8)
United States (7214)
Vaccines (211)
Venture capitalists (27)
Webinars (10)
Weight loss (90)
Women's health (13)
Worklife (15)
Date
Today (40)
Last 7 days (256)
Last 30 days (1007)
Last 365 days (12650)
2025 (3082)
2024 (13630)
2023 (15603)
2022 (20543)
2021 (22104)
2020 (20373)
2019 (17518)
2018 (12864)
2017 (12825)
2016 (12425)
2015 (13865)
2014 (10339)
2013 (8911)
2012 (9433)
2011 (9729)
2010 (9036)
Location
Africa (382)
Alabama (22)
Alaska (4)
Arizona (69)
Arkansas (4)
Asia (28254)
Australia (3806)
California (1834)
Canada (712)
China (241)
Colorado (90)
Connecticut (73)
Delaware (72)
Europe (36721)
Florida (259)
Georgia (56)
Hawaii (1)
Idaho (11)
Illinois (135)
India (19)
Indiana (138)
Iowa (5)
Japan (108)
Kansas (30)
Kentucky (7)
Louisiana (4)
Maine (9)
Maryland (241)
Massachusetts (1450)
Michigan (92)
Minnesota (122)
Mississippi (1)
Missouri (32)
Montana (4)
Nebraska (9)
Nevada (12)
New Hampshire (13)
New Jersey (644)
New Mexico (16)
New York (675)
North Carolina (355)
North Dakota (7)
Northern California (842)
Ohio (64)
Oklahoma (6)
Oregon (16)
Pennsylvania (295)
Puerto Rico (3)
Rhode Island (8)
South America (462)
South Carolina (5)
Southern California (652)
Tennessee (31)
Texas (232)
Utah (51)
Virginia (61)
Washington D.C. (24)
Washington State (141)
Wisconsin (34)
249,059 Results for "enzyvant sciences ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer
March 11, 2025
·
3 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
Lobe Sciences Ltd., a biopharmaceutical company focused on developing transformative medicines to treat rare diseases and Clearway Global, LLC, a wholly owned subsidiary of Sancilio & Company, a pharmaceutical services company focused on value creation strategies, are pleased to announce a change in control of the Company and several enhancements to its ongoing growth strategy.
May 21, 2024
·
5 min read
Press Releases
International Medication Systems, Ltd. Receives FDA’s Drug Shortage Assistance Award
March 31, 2025
·
5 min read
Deals
Enzyvant Announces Merger with Altavant
Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of Sumitovant Biopharma Ltd., today announced a merger to form a biopharmaceutical company focused on delivering life-altering therapies for people with rare diseases.
December 6, 2022
·
8 min read
1 of 24,906
Next
